Pilot Study to Collect and Evaluate Data on the Use of IV* Ibuprofen in the Treatment of an Acute Migraine Attack

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2017

Conditions
Episodic Migraine
Interventions
OTHER

saline placebo

250 cc of placebo administered IV

DRUG

Ibuprofen

800 mg ibuprofen in 250 cc saline administered IV

Trial Locations (1)

19107

Jefferson Headache Center, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT01230411 - Pilot Study to Collect and Evaluate Data on the Use of IV* Ibuprofen in the Treatment of an Acute Migraine Attack | Biotech Hunter | Biotech Hunter